British Liver Transplant Group
The BLTG (British Liver Transplant Group) was launched in 2014 to represent the professional interests of liver transplantation in the UK and promote strategic and academic development.
The BLTG will foster close relationships with BTS (British Transplant Society) and LICAGE (Liver Intensive Care Group of Europe) and will build on the role of the UK and Ireland Annual Meeting by delivering structure and authority to the group.
BLTG Transplant Meetings
The annual BLTG meeting will integrate the meetings previously organised by each individual transplant centre but will extend to the many individuals working outwith liver transplant centres with an interest in liver transplantation. The meeting will offer a platform for those operating in or with a strong interest in the field of liver transplantation. The BLTG Transplant meeting will be linked to the BASL Annual Meeting and will be aligned to the Liver Transplant Symposium and Williams-Calne Lecture within that programme. The winner of the Andy Burroughs Young Investigator Award will also deliver their prize lecture during the BTLG meeting. The BASL BLTG School of Transplantation offers an excellent platform for trainees with lectures delivered by carefully selected leading speakers from the UK.
The Work of the BLTG
BLTG will provide a voice for UK liver transplantation bringing together all clinicians and allied personnel involved or interested in liver transplantation in the UK. By working closely with allied bodies such as the Liver Advisory Group to NHSBT, the British Transplant Society, BASL, BSG, AUGIS and LICAGE, BLTG will provide the professional view on aspects of planning and delivering liver service for the UK, including liver transplantation. There will also be a strong emphasis on education and training and setting out the future needs of UK Liver services / transplantation.
The BLTG Committee
|BLTG Chair||Professor Derek Manas, Freeman Hospital, Newcastle upon Tyne|
|BLTG Secretary||Dr Andrew Holt, Queen Elizabeth Hospital, Birmingham|
|Conference and Education Lead||Dr Joanna Leithead, Addenbrookes Hospital, Cambridge|
|Transplant Hepatology representative||Dr Steven Masson, Freeman Hospital, Newcastle Upon Tyne|
|Transplant Surgery Representative||Professor Brian Davidson, Royal Free Hospital, London|
|Pathology representative||Dr Tim Kendall, University of Edinburgh and Royal Infirmary of Edinburgh|
|Pharmacy representative||Amanda Smith, University Hospitals Birmingham|
|BSG representative||Yiannis Kallis, Royal London Hospital|
|Transplant Co-ordinator||Sarah Coate, King’s College Hospital, London|
|Nursing Representative||Kate Jones, St James’ University Hospital, Leeds|
|Paediatric representative||Dr Marianne Samyn, Kings College, London|
|Patient Representative||Martine Walmsley, PSCS support|
|Patient Representative||British Liver Trust Representative|
|BASL representative (Treasurer)||James Ferguson, Queen Elizabeth Hospital, Birmingham|
|BTS Representative||Mr Krishna Menon, Kings College, London|
|Association of Upper Gastrointestinal Surgeons (AUGIS) representative||TBC|
|Substance misuse specialists (SMSLT) representative||Liz Shepherd, Royal Free Hospital, London|
|Interventional Radiology representative||Dr Jai Patel, Leeds Teaching Hospital|
|Anaesthetic Representative||Dr Suehana Rahman, Royal Free Hospital, London|
||Dr Brian Hogan, Kings College, London|
Professor Derek Manas, Freeman Hospital, Newcastle upon Tyne
Professor Manas is a Consultant HPB and Transplant Surgeon, Newcastle upon Tyne. He is a Professor of Transplantation Surgery and Director of the Institute of Transplantation at the Freeman Hospital, Newcastle upon Tyne. Professor Manas trained in Cape Town, Johns Hopkins and Paris. He is President Elect of the British Transplant Society and Chair of the Transplant Surgeons Chapter. His interests cover the Management of HCC, Surgical Management of Hilar Cholangiocarcinama, Ablative therapies for Liver and Pancreas Tumours and the use of Marginal organs for Transplantation.
Dr Andrew Holt, Queen Elizabeth Hospital, Birmingham / University of Birmingham
Andrew is a Consultant Physician and Transplant Hepatologist based at the Liver Unit in Queen Elizabeth Hospital, Birmingham and a Senior Researcher at the University of Birmingham. Andrew moved to the Birmingham Liver Transplant Unit in 2002 and was the Clinical Service Lead until 2018. His particular interests are in addiction-related liver disease and transplantation and he leads the multidisciplinary High Intensity Clinic for complex disease management. His research interests are predominantly based around the management of decompensated liver disease and he holds a PhD from the University of Birmingham for his work studying stromal immune interactions within the liver.
Dr Joanna A Leithead, MBChB MD MRCP, Consultant in Hepatology and Liver Transplantation, Addenbrookes Hospital Cambridge
Dr Joanna A Leithead, MBChB MD MRCP is a Consultant in Hepatology and Liver Transplantation in Addenbrookes Hospital, Cambridge, UK. She has more than 10 years of experience in transplant centres, including 3 years in the Royal Infirmary of Edinburgh researching aspects of portal hypertension and 5 years as the Clinical Lecturer in Hepatology in the Queen Elizabeth Hospital Birmingham. Her main active research focus is the role that liver graft injury plays in the development of renal injury. Her clinical interests are complications of portal hypertension and liver transplantation. She is a member of the NHSBT Liver Advisory Group, and the Conference and Education Lead for the British Liver Transplant Group.
Dr Steven Masson, Consultant in Hepatology and Liver Transplantation, Freeman Hospital, Newcastle Upon Tyne
Steven Masson is a Consultant Hepatologist at the regional Liver and Transplant Unit at the Freeman Hospital, Newcastle and Institute of Cellular Medicine, Newcastle University. His clinical and research interests are focused around alcohol-related liver disease, haemochromatosis and liver transplantation. He is the Hepatology speciality group lead for the North East and Cumbria LCRN. He is the consultant lead for the alcohol liaison team at the Newcastle Hospitals. He graduated from Edinburgh University and subsequently trained in hepatology and liver transplantation in Edinburgh, Newcastle and London.
Professor Brian Davidson, Royal Free Hospital, London
Professor Davidson is a consultant surgeon with a major interest in HPB surgery and liver transplant. He is UK editor of the Cochrane HPB group for evidence based healthcare and director of the UCL MSc in evidence based medicine. He works closely with patient groups on research advances in the HPB field and leads a research programme involving evidence based healthcare, organ preservation and tissue engineering, image guided surgery and novel approaches to the treatment of HPB cancers.
Dr Tim Kendall, Senior Clinical Fellow in Pathology, University of Edinburgh and Honorary Consultant Liver Pathologist, Royal Infirmary of Edinburgh
Dr Kendall's research interests are liver fibrogenesis and primary liver cancer but he provides histopathological support for many other preclinical, translational and clinical studies. He is a member of the UK Liver Pathology group research subcommittee, and he promotes histopathological involvement in trials through membership of the CM-Path Clinical Trials workstream, the NCRI Hepatobiliary CSG subgroup, and his role within the Lothian NRS Human Annotated Bioresource. Dr Kendall graduated from Southampton University Medical School, and trained in pathology in Southampton and Edinburgh.
Amanda Smith, University Hospitals Birmingham
Amanda Smith graduated from Nottingham University, and subsequently trained in Leeds and Derby gaining a postgraduate diploma in clinical pharmacy, before joining Aston University as a teacher practitioner. She has been the lead liver pharmacist at University Hospitals Birmingham since 2002, and is an active member of the UK & Eire Liver Transplant Pharmacists’ Group. Her clinical interests include patient medication adherence, patient information, drug interactions in transplantation, and normothermic machine perfusion.
Dr Yiannis Kallis, Royal London Hospital
Yiannis Kallis is a Consultant Hepatologist at the Royal London Hospital and Honorary Transplant Hepatologist at the Royal Free Hospital. He runs an outreach liver transplant service for NE London and is Clinical Lead for Hepatology at the Royal London Hospital. He was awarded a PhD from Imperial College London in 2010 for his work on stem cells in liver fibrosis regeneration and is an Honorary Clinical Senior Lecturer at QMUL. His current clinical and research interests are in PBC, cholangiopathies (PSC and IgG4 related disease), coagulation in liver disease and advanced ERCP.
Sarah Coate, King’s College Hospital, London
Sarah Coate studied for her first degree at Leeds University in Psychology before training as a nurse. Once she gained her nursing qualification she worked on cardio-thoracic intensive care at St George's for 18 months before transferring to Liver Intensive Care at Kings College Hospital in 2005. She was a junior sister in charge charge of the Liver ITU, a Practice Development Educator and joined the Transplant Coordinator team in 2008. She has experience of looking after both pre and post-transplant patients and has coordinated the Outpatient Pre-assessment clinic for 3 years, working closely with the MDT. She then took on the Lead Coordinator role for Transition Care and Health Promotion clinic. Her specific interests are; non adherence post-transplant, pregnancy post-transplant, transition from paediatric to adult services, management of obesity, diabetic control, and hypertension post transplant and nurse led transplant asessment clinics. She regularly participates in the On Call Service for Liver Transplant at King's and is involved in receiving liver offers, selection of recipients, preparation of recipients for theatre, and the coordination of surgical teams.
Kate Jones, St James’ University Hospital, Leeds
Kate Jones qualified in Australia and worked in Sydney within the transplant unit before moving to the UK in 2002. She has worked within liver services for a number of years and for the last 9 years has worked as a liver transplant co-ordinator in London and Leeds. Her role as liver transplant co-ordinator is varied and she is involved in pre assessment, waiting list management and post transplant care.
Dr Marianne Samyn, Kings College, London
Dr Samyn has been a consultant paediatric hepatologists at King’s College Hospital since 2004 and a clinical lead for the multidisciplinary liver transition service since the set up in 2009. With an interest in adolescent medicine, longterm outcome of paediatric liver diseases and paediatric liver transplantation and autoimmune liver disease.
Mr Krishna Menon, Kings College, London
Mr Menon is a Consultant Liver Transplant and Hepatopancreatobiliary Surgeon who has recently been appointed to the King’s College Hospital NHS Foundation Trust in January 2013. Previously, he was Consultant Surgeon from January 2002 to December 2012 at the Leeds Teaching Hospitals NHS Trust with a specialist interest in Transplantation and Hepato-pancreatobiliary surgery. Over the years as a Consultant at the Leeds Teaching Hospitals NHS Trust and currently, he has helped develop techniques in transplantation and HPB surgery. Currently, at King’s College Hospital he is a part of a Consultant Team that is arguably one the leading liver transplant centers in the United Kingdom and worldwide. He is also the National Councillor for Liver Transplant on the British Transplant Society.
Liz Shepherd RGN, RMN, Royal Free Hospital, London
Liz Shepherd is lead Specialist Nurse in substance misuse and liver transplantation based at Royal Free liver transplant unit, providing specialist substance misuse input to patients undergoing liver transplantation. She has worked with patients who have problematic alcohol use since 1992 and also set up and developed an alcohol liaison service to the Whittington hospital. Since 2004 Liz has developed the role and value of substance misuse assessment in the context of liver transplantation in the UK. This has led to the development of the UK national guidelines for alcohol and liver transplantation (Lancet 2006) and also for transplantation in the context of illicit drug use (2007). She is a founder member of the SMSLT bringing together specialists in this area from across the UK. Liz was a member of the Department of Health working group on delivering IBA in hospital settings (2011) and was a clinical advisor for the NCEPOD report “Measuring the Units” (2013). More recently she was an active member of the working group rewriting the LAG alcohol guidelines (2016 in press) and acted as a script advisor to EastEnders ArLD liver transplant storyline (2016/17). She is the current Chair of SMSLT and is their representative on BLTG committee.
Dr Jai Patel, Leeds Teaching Hospitals NHS Trust (LTHT)
Dr Patel was appointed as consultant in vascular and interventional radiology at LTHT in 1999. Together with other colleagues in the department he provides a comprehensive specialist vascular radiology service in a wide range of minimally invasive interventions. His main area of interest and expertise is in liver intervention, specifically in trans-arterial therapies for the treatment of liver tumours and interventional radiological management of portal hypertension (cirrhotic, non-cirrhotic and Budd-Chiari syndrome). His practice includes intervention in both adult and paediatric liver patients. He was previously Lead Clinician for vascular radiology at LTHT for 5 years and remains the lead interventionalist for the liver service in Leeds. Previous committee work has included Education Committee Chairman and Secretary of the British Society of Interventional Radiology. He also has an interest in the use of new medical devices and technologies in patient management, and is currently a committee member of the NICE Medical Technologies Advisory Committee.
Dr Suehana Rahman, Royal Free Hospital, London
Dr Suehana Rahman MBBS BSc (Hons) FRCA, is a Consultant Hepatobiliary and Liver Transplant Anaesthetist at the Royal Free Hospital, London. During her transplant fellowship she undertook research in cirrhotic cardiomyopathy and acute kidney injury after transplantation. She is an active member of the Royal Free Perioperative Research Group and current anaesthetic representative for the British Liver Transplant Group.
Dr Brian Hogan, Kings College, London
Dr Hogan qualified from University College London Medical School in 2004. He completed Specialist Training in Critical Care Medicine and Hepatology at King's College Hospital, The Royal Free Hospital and Guy's and St Thomas' Hospitals before joining King's as a Consultant in 2018. Whilst training he completed research at The Royal Free Hospital and University College London investigating novel methods of assessing portal hypertension in patients with severe liver disease.
He works as a Consultant in both Critical Care Medicine and Hepatology.